Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Image ALS: Multimodal Imaging Outcome Measures
NCT04490096Phase 1Terminated
- Sponsor
- University of Pennsylvania
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Pennsylvania. Primary endpoints: Volume measurement of brain regions using MRI at 12 months, Thickness measurement of brain regions using MRI at 12 months and 1 more. Started Feb 2021; status: terminated.
Beyond the preview
Go deeper on NCT04490096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04490096.